relative to establishing a committee to study the impact of pharmacy benefit manager operations on cost, administration, and distribution of prescription drugs.

This bill establishes a legislative committee to investigate how pharmacy benefit managers influence the cost, administration, and distribution of prescription drugs in New Hampshire. The committee, composed of one senator and three representatives, will examine specific issues such as the impact of clawbacks, steering practices toward mail-order pharmacies, and the role of plan design in consumer pricing. By soliciting testimony from relevant experts and entities, the group aims to understand these operational effects and determine if new oversight measures could lower drug costs. The committee is required to submit its findings and any legislative recommendations to state officials and the governor by November 1, 2024.